ANIP
ANI Pharmaceuticals Inc
74.40$
-4.5%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -0.1% | +4.4% | +0.4% | +7.5% | +28.5% | +3.4% | +7.2% | +7.8% | +8.4% | -3.9% | +12.0% | – | |
| – | +11.1% | -8.0% | +17.4% | +9.3% | +27.3% | -9.0% | +2.2% | +55.5% | -91.8% | +1,105.3% | -12.5% | – | |
| – | -6.6% | +12.8% | -9.0% | +6.1% | +29.4% | +12.5% | +10.2% | -18.3% | +112.5% | -48.2% | +34.9% | – | |
| – | -11.3% | +6.5% | -30.6% | +38.8% | +64.4% | -36.5% | +56.5% | -25.6% | -0.3% | -13.5% | +39.1% | – | |
| – | +5.8% | +8.0% | +10.0% | +49.7% | -11.8% | +9.8% | +6.9% | -6.3% | -0.2% | -3.8% | +24.4% | – | |
| – | +8.7% | -5.0% | +10.6% | +40.7% | +8.4% | -14.6% | +25.5% | -27.6% | +112.9% | -55.5% | +48.9% | – | |
| – | -62.5% | +202.0% | -74.6% | -497.0% | – | – | -47.0% | +64.4% | +111.0% | -19.7% | +4.5% | – | |
| – | -10.2% | -19.9% | +1.2% | -49.9% | +158.0% | +34.8% | +1.4% | -42.5% | +383.2% | -83.5% | -3.5% | – | |
| – | -91.8% | +2,575.3% | -109.0% | – | – | – | -47.3% | +221.1% | -6.9% | +27.8% | -7.8% | – | |
| – | -113.2% | – | – | – | – | – | -54.1% | +263.5% | -44.5% | +169.0% | +15.4% | – | |
| – | -88.4% | +1,476.4% | -112.6% | – | – | – | -45.5% | +182.3% | +13.9% | +7.3% | -16.2% | – | |
| – | -33.9% | +103.9% | -61.8% | -178.6% | – | +225.6% | -18.9% | +55.8% | +25.8% | -25.4% | +5.2% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.